Castor Raises $45M Series B to Modernize Clinical Trial Process
Castor, a leading provider of clinical trial software, announced today the closing of a $45 million Series B financing round, bringing the company’s total funding...
Category : Clinical Intelligence/Clinical Efficiency
Nimbus Therapeutics Raises $105 Million to Advance Clinical Programs
Multiple Phase 2 studies of allosteric TYK2 inhibitor in 2021 and 2022 will investigate ‘pipeline-in-a-product’ potential – Financing will also support first-in-human trial of HPK1...
Exscientia Accelerates COVID-19 Drug Discovery Using AI
Funding from the COVID-19 Therapeutics Accelerator to advance Exscientia’s novel class of AI-designed coronavirus SARS-CoV-2 Mpro inhibitors to development candidates Exscientia has received a grant from...
4G Clinical Announces $230M Growth Equity Investment
The innovative RTSM leader grew over 100% in 2020, plans to accelerate global expansion and support critical demand for products and services 4G Clinical, a...
Apervita Uses Carta Healthcare’s AI-Driven Clinical Data Abstraction
Addition of technology to save clinicians hours manually documenting quality measurement data Apervita, the trusted platform for healthcare collaboration, today announced that it has added Carta Healthcare’s artificial...
RNAi Therapeutics Developer Sirnaomics Secures $105 Million
Proceeds to Fund Development of Novel RNAi Therapeutics for Cancers, Viral Infections, Fibrosis, and Metabolic Diseases Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development...
Clinical Stage Radiopharmaceutical Co. Oncoinvent Secures NOK 250M
Norwegian radiopharmaceutical company announces successful closing of a private placement that will allow the company to initiate the next phase of clinical development of its...
Lyndra Therapeutics Completes $60.5 Million Series C Financing
Lyndra Therapeutics, a clinical-stage biotechnology company pioneering a novel technology platform that transforms daily pills into once-weekly to monthly oral treatment options, today announced the...
NCCA Selects Deep Lens’ AI-Based Clinical Trial Matching Solution
Agreement provides NCCA sites access to VIPER™ and other Deep Lens services to improve clinical trial recruitment efficiency Partnership will also expand clinical trial offering to...
Nucleai and Merck KGaA Darmstadt, Germany Launch Medicine Collab
Nucleai (www.nucleaimd.com), a precision medicine company using AI-powered image analysis technology to support novel pathology-based biomarker development, and Merck KGaA, Darmstadt, Germany, a leading science...